Bioverge is a venture capital firm specializing in emerging healthcare startups
Bioverge is a venture capital firm specializing in emerging healthcare startups. The firm operates Bioverge.com, an investment platform that aims to democratize access to startups solving healthcare’s biggest challenges and accelerate their progress.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
May 9, 2022
Aspen Neuroscience
|
Series B | $147.50M | Biotechnology | — |
|
Sep 13, 2021
NutriSense
|
Seed | $3.80M | Apps | — |
|
Jun 15, 2021
Enveda Biosciences
|
Series A | — | Biotechnology | — |
|
May 25, 2021
Juno Diagnostics
|
Series A | — | Biotechnology | — |
|
Oct 24, 2017
Ligandal
|
Seed | — | Biotechnology | — |